Swapna Uplekar
Impact in
- Infectious Diseases top 2%
- Tuberculosis Research and Epidemiology
- Molecular Medicine top 2%
- Antibiotic Resistance in Bacteria
Papers in
-
- Tuberculosis Research and Epidemiology 16
- Epidemiology 14
- Mycobacterium research and diagnosis 12
- Pneumocystis jirovecii pneumonia detection and treatment 2
- Co-authors
- Stewart T. Cole (11 shared papers)Ruben C. Hartkoorn (4 shared papers)Claudia Sala (7 shared papers)Jacques Rougemont (5 shared papers)Florence Pojer (2 shared papers)Jeffrey M. Chen (2 shared papers)Christophe Guilhot (2 shared papers)Stephen V. Gordon (2 shared papers)
- Journals
- Infection and Immunity (3 papers)Journal of Clinical Microbiology (2 papers)PLoS Pathogens (2 papers)Scientific Reports (1 paper)Journal of Bacteriology (1 paper)
- Partner nations
- SwitzerlandUnited StatesUnited Kingdom
In The Last Decade
Swapna Uplekar
22 papers receiving 1.2k citations
Hit Papers
Peers
Comparison fields: 5 of 60
- Infectious Diseases 905
- Molecular Medicine 171
- Epidemiology 740
- Molecular Biology 490
- Applied Microbiology and Biotechnology 9
Countries citing papers authored by Swapna Uplekar
This map shows the geographic impact of Swapna Uplekar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Swapna Uplekar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Swapna Uplekar more than expected).
Fields of papers citing papers by Swapna Uplekar
This network shows the impact of papers produced by Swapna Uplekar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Swapna Uplekar. The network helps show where Swapna Uplekar may publish in the future.
Co-authors
The 25 scholars most cited alongside Swapna Uplekar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Cross-Resistance between Clofazimine and Bedaquiline through Upregulation of MmpL5 in Mycobacterium tuberculosis Hit paper breakdown → | 2014 | 334 |
| 2 | 2012 | 143 | |
| 3 | 2014 | 116 | |
| 4 | 2012 | 106 | |
| 5 | 2020 | 89 | |
| 6 | 2011 | 61 | |
| 7 | 2011 | 55 | |
| 8 | 2009 | 52 | |
| 9 | 2012 | 41 | |
| 10 | 2012 | 41 | |
| 11 | 2012 | 39 | |
| 12 | 2012 | 38 | |
| 13 | 2016 | 35 | |
| 14 | 2016 | 15 | |
| 15 | 2024 | 13 | |
| 16 | 2015 | 9 | |
| 17 | 2023 | 4 | |
| 18 | 2022 | 4 | |
| 19 | 2024 | 3 | |
| 20 | 2024 | 2 |
About Swapna Uplekar
Swapna Uplekar is a scholar working on Infectious Diseases, Epidemiology, Molecular Biology, Surgery and Public Health, Environmental and Occupational Health, having authored 22 papers that have together received 1.2k indexed citations. Recurring topics across this work include Tuberculosis Research and Epidemiology (16 papers), Mycobacterium research and diagnosis (12 papers), RNA and protein synthesis mechanisms (5 papers), Malaria Research and Control (3 papers), Bacterial Genetics and Biotechnology (2 papers), Pneumocystis jirovecii pneumonia detection and treatment (2 papers), Bacterial Identification and Susceptibility Testing (2 papers) and Diagnosis and treatment of tuberculosis (2 papers). The work is most often cited by research in Infectious Diseases (905 citations), Molecular Medicine (171 citations), Epidemiology (740 citations), Molecular Biology (490 citations) and Applied Microbiology and Biotechnology (9 citations). Swapna Uplekar has collaborated with scholars based in Switzerland, United States and United Kingdom. Frequent co-authors include Stewart T. Cole, Ruben C. Hartkoorn, Claudia Sala, Jacques Rougemont, Florence Pojer, Jeffrey M. Chen, Christophe Guilhot, Stephen V. Gordon, Karl‐Heinz Altmann and Sophie Magnet. Their work appears in journals such as Infection and Immunity, Journal of Clinical Microbiology, PLoS Pathogens, Scientific Reports and Journal of Bacteriology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.